Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-06-22
1990-01-16
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546116, A61K 3144, C07D491048
Patent
active
048943789
ABSTRACT:
Blood sugar levels are reduced by administration of novel 4-thienyl-dihydropyridines of the formula ##STR1## in which R.sup.1 represents 1 or 2 halogen atoms, or represents straight-chain, branched or cyclic alkyl with up to 8 carbon atoms,
REFERENCES:
patent: 4145432 (1979-03-01), Sato
patent: 4532248 (1985-07-01), Franckowiak et al.
patent: 4647568 (1987-03-01), Gorlitzer et al.
patent: 4801715 (1989-01-01), Goldmann et al.
Bender Joachim
Bischoff Hilmar
Goldmann Siegfried
Petzinna Dieter
Puls Walter
Bayer Aktiengesellschaft
Dentz Bernard I.
Lee Mary C.
LandOfFree
Lowering blood sugar with novel 4-thienyl-dihydropyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lowering blood sugar with novel 4-thienyl-dihydropyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lowering blood sugar with novel 4-thienyl-dihydropyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1335018